Karatani and Hayashi (2004) also considered four phases for the recovery process after the 1995 Hanshin-Awaji or Kobe earthquake, but included an additional predisaster phase designated "Phase 0" that started 2 years before the earthquake.
All studies were designated phase II biomarker studies.
The first 6 months of the study, during which no therapy changes were permitted unless the investigator deemed it necessary for good clinical practice, was designated Phase 1.
Early exploratory studies are designated phase I studies, whereas phase II studies investigate the association of a biomarker with patient prognosis and are hypothesis generating in nature, and phase III studies are large confirmatory studies of prestated hypotheses.
In the current study, we combined data from those 1992 individuals (designated as phase 1) with 655 additional men who had been subsequently diagnosed with prostate cancer (up to 2006) and their 655 matched control participants (designated phase 2), whose samples were assayed in 2009.
Each detector should have a designated phase-out age, so remember to replace them at the appropriate time.
The existence of these two extremely different forms or phases, also designated as phase polyphenism, is a fascinating example of phenotypic plasticity, whereby two obviously different phenotypes are encoded by the same genome [9] [11].
Based on the resulting measurements, the cells seemed to respond to the treatment in three different phases designated the initial response phase (0 0.5 h), the intermediate acclimation phase (3 12 h) and the late acclimation phase (12 48 h).
The splicing phases were designated as three splicing phases: phase 0, splicing occurred after the third nucleotide of the codon; phase 1, splicing occurred after the first nucleotide of the codon; and phase 2, splicing occurred after the second nucleotide.
This compound has been recently designated for phase III clinical trials to test its efficacy for treating epilepsy and providing relief of neuropathic pain.
